Belarus Pharmaceuticals and Healthcare Report Q3 2013: Business Monitor International Market Research Reports

Business Monitor International Market Research Reports Market Reports Online XML Feed

Belarus Pharmaceuticals and Healthcare Report Q3 2013 Aug 7th 2013, 00:00 Price: $ 1295   BMI View: We view Belarus's pharmaceutical market as having modest longer-term potential, although this potential will continue to be hampered by factors such as insufficient healthcare provision and a challenging intellectual property (IP) environment. Although the authorities are striving to improve domestic pharmaceutical production capabilities, demand will have to continue to be met through imports. Risks to our outlook include the weakness of local currency, corruption, the country's isolationist political stance and the uncertain economic outlook, with the state still highly involved in many sectors. Headline Expenditure Projections: ? Pharmaceuticals: BYR6,543bn in 2012 (US$783mn) to BYR8,376bn (US$959mn) in 2013; +28.0% in local currency terms and +22.5% in US dollar terms. Forecast ... Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/266730.html

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions